Address correspondence to Dr Stephen Goutman, Department of Neurology, F2647 UH SOUTH, SPC 5223, 1500 E Medical Center Dr, Ann Arbor, MI 48109, [email protected].
Relationship Disclosure: Dr. Goutman has consulted for Cytokinetics, Inc, and has received research/grant support from the Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention; the ALS Association; the National Institutes of Health/National Institute of Environmental Health Sciences (K23ES027221); Neuralstem, Inc; and Target ALS.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Goutman discusses the unlabeled/investigational use of amitriptyline, atropine, botulinium toxin, citalopram, and mexiletine for the symptomatic management of amyotrophic lateral sclerosis.